| Product Code: ETC329529 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) In-vitro Diagnostics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) In-vitro Diagnostics Market - Industry Life Cycle |
3.4 United Kingdom (UK) In-vitro Diagnostics Market - Porter's Five Forces |
3.5 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume Share, By Product & Solution, 2021 & 2031F |
3.6 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Kingdom (UK) In-vitro Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the UK leading to higher demand for in-vitro diagnostics. |
4.2.2 Technological advancements in the field of diagnostics driving innovation and product development. |
4.2.3 Growing aging population in the UK increasing the need for diagnostic testing services. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of in-vitro diagnostic products leading to longer time-to-market. |
4.3.2 Limited reimbursement policies impacting the adoption of new diagnostic technologies. |
4.3.3 High cost associated with in-vitro diagnostic tests affecting affordability for patients and healthcare providers. |
5 United Kingdom (UK) In-vitro Diagnostics Market Trends |
6 United Kingdom (UK) In-vitro Diagnostics Market, By Types |
6.1 United Kingdom (UK) In-vitro Diagnostics Market, By Product & Solution |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Product & Solution, 2021 - 2031F |
6.1.3 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Consumables, 2021 - 2031F |
6.1.4 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Systems, 2021 - 2031F |
6.1.5 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Software & Services, 2021 - 2031F |
6.2 United Kingdom (UK) In-vitro Diagnostics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Immunoassay/ Immunochemistry, 2021 - 2031F |
6.2.3 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Biochemistry/Clinical Chemistry, 2021 - 2031F |
6.2.4 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Microbiology, 2021 - 2031F |
6.2.5 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Hematology, 2021 - 2031F |
6.2.6 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Coagulation/Hemostasis, 2021 - 2031F |
6.2.7 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Urinalysis, 2021 - 2031F |
6.3 United Kingdom (UK) In-vitro Diagnostics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.4 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Endocrinology, 2021 - 2031F |
6.3.5 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Diabetes, 2021 - 2031F |
6.3.6 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.7 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Nephrology, 2021 - 2031F |
6.4 United Kingdom (UK) In-vitro Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Diagnostic Reference Laboratories, 2021 - 2031F |
6.4.3 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2021 - 2031F |
6.4.4 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Home Healthcare, 2021 - 2031F |
6.4.5 United Kingdom (UK) In-vitro Diagnostics Market Revenues & Volume, By Other, 2021 - 2031F |
7 United Kingdom (UK) In-vitro Diagnostics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) In-vitro Diagnostics Market Export to Major Countries |
7.2 United Kingdom (UK) In-vitro Diagnostics Market Imports from Major Countries |
8 United Kingdom (UK) In-vitro Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of new in-vitro diagnostic technologies in the UK healthcare system. |
8.2 Number of partnerships and collaborations between in-vitro diagnostic companies and healthcare providers in the UK. |
8.3 Rate of utilization of in-vitro diagnostics in preventive healthcare programs in the UK. |
9 United Kingdom (UK) In-vitro Diagnostics Market - Opportunity Assessment |
9.1 United Kingdom (UK) In-vitro Diagnostics Market Opportunity Assessment, By Product & Solution, 2021 & 2031F |
9.2 United Kingdom (UK) In-vitro Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United Kingdom (UK) In-vitro Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United Kingdom (UK) In-vitro Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Kingdom (UK) In-vitro Diagnostics Market - Competitive Landscape |
10.1 United Kingdom (UK) In-vitro Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) In-vitro Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here